Page 225 - Eshre Final Programme 2015

P-411 The influence of female overweight and obesity on the outcomes of assisted reproductive technology treatment: the experience of a Portuguese center
T. Simoes1, C. Julio1, S. Figueiredo1, G. Silva1, S. Pinto1, M. Rato1, S. Correia1, J. Gonçalves1, G. Pinto1
1Maternidade Alfredo Da Costa - CHLC, Reproductive Medicine, Lisboa, Portugal
P-412 Assessment of uterine, subendometrial blood flows and endometrial gland vascular endothelial growth factor (EG-VEGF) in women with unexplained infertility
A. Elnaggar1, M. Abdel-Hafeez2, H. El-Zenneni2, R. Moustafa2, H. El-Salally3, A. Abdel-Kader2
1Jersey General Hospital, Obstetrics Gynecology, Jersey, United Kingdom 2Ain Shams University, Obstetrics Gynecology, Cairo, Egypt
3Ain Shams University, Pathology, Cairo, Egypt
P-413 Frozen embryo transfer protocols: a comparison of clinical pregnancy and delivery rates
M. Healey1, T. Osianlis2, L. Rombauts3
1University Melbourne, Department Obstetrics & Gynaecology, Melbourne, Australia 2Monash IVF, Embryology, Melbourne, Australia
3Monash University, Department Obstetrics & Gynaecology, Melbourne, Australia
P-414 Blastocyst development and pregnancy outcome of the frozen- embryo transfers are similar after GnRH agonist or HCG triggerring in patients at risk of OHSS
A.P. Cil1, S. Selcuk1, Z. Atayurt1, H. Yelke1, Y. Kumtepe1, S. Kahraman1
1Istanbul Memorial Hospital, IVF, Istanbul, Turkey
P-415 Müllerian malformations in an Assisted Reproductive Technologies Center: clinical implications
T. Lima1, A.S. Cardoso1, M.I. Sá1, A. Pinto1, C. Leal1, S. Fraga1, C. Lourenço1, M. Barreiro1, I. Sousa Pereira1, J. Mesquita Guimarães1
1Centro Hospitalar do Porto, Departamento da Mulher e da Reprodução, PORTO, Portugal
P-416 Decreased healthcare resource utilization among women undergoing IVF/ICSI treated with GnRH antagonist protocols as compared to GnRH agonist protocols
W. Ledger1, S. Crespi2, H. Hu2, E.M. Kolibianakis3, G. Griesinger4
1University of New South Wales, School of Women's & Children's Health Royal Hospital for Women, Randwick NSW, Australia
2Merck & Company Inc, Centre for Observational Research and Real World Evidence, Kenilworth, U.S.A.
3Aristotle University of Thessaloniki, Medical School 1st Department of Obstetrics and Gynecology, Thessaloniki, Greece
4University of Lubeck, Department of Gynecological Endocrinology and Reproductive Medicine, Lubeck, Germany
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 225
POSTERS